Skip to main content

Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown

Board Will Add to Company's Intellectual Capital and Diversity of Experience

LAS VEGAS, NV / ACCESSWIRE / October 15, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce William Padilla-Brown as the inaugural candidate for its Scientific and Cultural Advisory Board. A renowned citizen scientist, author, speaker, and mycology thought leader, Padilla-Brown has continually pushed the boundaries of mycological research and public education, making groundbreaking contributions to the cultivation and understanding of fungi.

Best known for authoring the first English-language book on Cordyceps cultivation, William has shaped how mycologists and enthusiasts alike approach this once-rare mushroom. His book has empowered growers across the globe to explore Cordyceps cultivation, previously a closely-guarded practice. His expertise doesn't stop there; William is a passionate advocate for decentralized research, spearheading the development of independent research facilities for both mycology and algae cultivation.

In addition to his academic contributions, William is the visionary behind MycoFest, a premier event in the mushroom world. MycoFest brings together mycology enthusiasts, researchers, and industry experts for networking, education, fostering collaboration across diverse sectors of the mushroom space. His ability to blend science with community has made him a vital connector in the growing global mycology movement.

At Hypha Labs, William's role will be critical as the Company explores new frontiers in mycology. His current focus includes highlighting the healing properties of truffles native to North America, bringing much-needed attention to their health and wellness benefits. His insights into this relatively untapped resource will guide future research at Hypha Labs, with the goal of broadening public awareness of these potent fungi.

"We're incredibly excited to have William Padilla-Brown joining us on this journey," said Stone Douglass, CEO at Hypha Labs. "His work aligns perfectly with our mission to advance decentralized, sustainable, and accessible mycological research. His expertise and passion for fungi will be invaluable as we continue to push the boundaries of what is possible in this field."

As Hypha Labs continues its mission to innovate in the world of mycology, William's leadership will be instrumental in shaping our research agenda and community initiatives. His unique blend of hands-on experience, scientific rigor, and community engagement is a perfect match for Hypha Labs' vision of a more connected, informed, and empowered mycological future.

About Hypha Labs, Inc.

The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.

SAFE HARBOR FORWARD LOOKING STATEMENTS:

This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.

From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:

LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/

Twitter: https://x.com/Hypha_Labs

For more information about Hypha Labs visit HyphaLabs.com

For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck

Investor and Media Relations:

Integrity MediaInc.
(888) 216-3595
team@integritymedia.com

Contact Information

Kurt Divich
President, Integrity Media Inc.
team@integritymedia.com
(888) 216-3595

SOURCE: Hypha Labs



View the original press release on accesswire.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.